Are Our Genes Really Our Fate? DNA’s Visual Culture and the Construction of Genetic Truth
By Kathleen Pierce,
Nursing Clio
| 04. 24. 2018
The direct-to-consumer genetic testing company 23andme has recently been described by journalist Erika Check Hayden as a “unicorn.” For Hayden, this Silicon Valley idiom describes the company’s one billion dollar valuation while also capturing the rare opportunity it affords to scientists: its two million customers make up the largest available pool of gene-linked health data. The home testing kit’s packaging does little to disrupt visual continuities with popular imaginings of unicorns: a matte, velvety white box has been striped along one edge with rainbow chromosomal pairs, their neat, parallel lines forming a multihued mane.
23andme’s use of saturated fields of color and streamlined, graphic shapes may seem part and parcel of 21st-century advertising and design trends favoring a minimalist aesthetic, sleek shapes, and bright pops of color. However, this visual style has long played a role in representations of genetic material in popular visual culture and scientific literature from the 1950s to today.
These images, particularly their use of simplified shapes and solid colors, help shape popular conceptions of ancestry, genetic disease, and hereditary traits as fixed and...
Related Articles
By Ryan Cross, Endpoints News | 09.02.2026
The deaths of two children who received CRISPR therapies in China have rattled scientists who work on similar genetic medicines in the US, adding new fuel to a yearslong debate about the danger of the gene therapy field’s most-used delivery...
By Maia Hibbett, Wired | 09.09.2026
THE INSTAGRAM POST, precision-guided by sex and age, had zeroed in on its target. Yuchen Tu is a conservatory-trained viola player from Chongqing, China, a lover of science fiction, and an aspiring member of the US Army Reserve Officer Training...
By Emily Packard Dawson and Lainie Friedman Ross, MedPage Today | 08.18.2026
Few things evoke a greater sense of desperation than a parent seeking an experimental treatment for their child. That desperation can make even extraordinary risks seem worth taking. This dynamic has come into stark relief after Mei, a 6-year-old girl...
By Claire Robinson and Jonathan Matthews, Guest Contributors
| 08.25.2026
This is an excerpt of an article originally published on August 1, 2026 at GMWatch.
A six-year-old girl has died in a gene editing gene therapy trial in China that went wrong, the journal Science reports. Seven days after the girl's medical team infused trillions of viruses carrying the recipe for the gene editing tool – in this case a base editor – into her spinal fluid, she died of a severe immune reaction linked to the therapy.
Just...